TCHP and neoplasm: This platform can effectively load the TP53 tumor suppressor protein, precisely deliver it to TP53-deficient ovarian cancer, inhibit tumor cell proliferation and induce apoptosis by restoring TP53 expression, and successfully suppress SKOV-3 tumor growth in in vivo experiments.141